KCNIP4-IT1: A Non-Coding RNA Molecule as A Drug Target and Biomarker

Target Name: KCNIP4-IT1

NCBI ID: G359822

KCNIP4-IT1

Other Name(s): NCRNA00099 | KCNIP4 intronic transcript 1 | UM9(5) | UM9-5

KCNIP4-IT1: A Non-Coding RNA Molecule as A Drug Target and Biomarker

KCNIP4-IT1 (NCRNA00099) is a drug target (or biomarker) that has been identified and characterized for its role in various diseases, including cancer. The protein encoded by this gene is a non-coding RNA molecule that has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and invasion.

One of the most significant aspects of KCNIP4-IT1 is its potential as a drug target. The use of drugs to target specific proteins, such as KCNIP4-IT1, has become a popular method for the treatment of various diseases. By inhibiting the activity of this protein, drugs can effectively treat conditions that are caused by the overproduction or dysfunction of the protein.

In addition to its potential as a drug target, KCNIP4-IT1 has also been identified as a biomarker for several diseases, including cancer. The use of KCNIP4-IT1 as a biomarker allows for the early detection and diagnosis of certain diseases, which can have a significant impact on treatment outcomes.

The identification and characterization of KCNIP4-IT1 as a drug target and biomarker is a significant milestone in the development of new treatments for various diseases. The use of this protein as a drug target has the potential to revolutionize the treatment of a wide range of conditions, including cancer.

Overview of the Protein

KCNIP4-IT1 is a non-coding RNA molecule that is characterized by its ability to regulate the expression of other genes. It is expressed in a variety of tissues and cells, including brain, spinal cord, and various types of cancer cells. The protein is composed of 21 amino acid residues and has a calculated molecular mass of 33.1 kDa.

The function of KCNIP4-IT1 is not well understood, but it is believed to play a role in the regulation of cellular processes, including cell adhesion, migration, and invasion. It is thought to function as a negative regulator of the F-actinin protein, which is involved in the regulation of cellular adhesion and migration.

In addition to its role in cellular processes, KCNIP4-IT1 is also known for its potential as a drug target. The use of drugs to target specific proteins, such as KCNIP4-IT1, has become a popular method for the treatment of various diseases. By inhibiting the activity of this protein, drugs can effectively treat conditions that are caused by the overproduction or dysfunction of the protein.

Potential Applications

The identification of KCNIP4-IT1 as a drug target has significant implications for the treatment of various diseases. The use of drugs to target specific proteins, such as KCNIP4-IT1, has the potential to revolutionize the treatment of a wide range of conditions, including cancer.

In addition to its potential as a drug target, KCNIP4-IT1 has also been identified as a biomarker for several diseases, including cancer. The use of KCNIP4-IT1 as a biomarker allows for the early detection and diagnosis of certain diseases, which can have a significant impact on treatment outcomes.

In conclusion, the identification and characterization of KCNIP4-IT1 as a drug target and biomarker is a significant milestone in the development of new treatments for various diseases. The use of this protein as a drug target has the potential to revolutionize the treatment of a wide range of conditions, including cancer. Further research is needed to fully understand its function and potential as a drug target and biomarker.

Protein Name: KCNIP4 Intronic Transcript 1

The "KCNIP4-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNIP4-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets